XYLO Medigus: Debt to Equity

The Xylo Technologies Ltd. (XYLO) price chart on the GURU.Markets platform demonstrates a total debt-to-equity ratio of 0.43. This investment holding (formerly Medigus) is currently monetizing its technological developments. Business growth relies on the acquisition of promising fintech projects and B2B services to capture the online market. The structural stability is based on medtech management and the support of innovative digital startups.

XYLO: Xylo Technologies Ltd. Aggregate Debt to Equity 04/20/2024 - 09/06/2025

Xylo Technologies - analytical breakdowns and key metrics (XYLO)

- price and consensus price forecast:

Price Chart Xylo Technologies Ltd|XYLO - Analyst Median Target

- company stock capitalization data:

Market Value Xylo Technologies|XYLO - Total Enterprise Value

- company book value details:

Book Value per Share Xylo Technologies|XYLO - Net Asset Value|Market Cap to Net Assets Ratio medigus.com|XYLO - Aggregate Business Assets

- issuer credit burden and liquidity indicators:

Total Debt to Equity Ratio Xylo Technologies Ltd.|XYLO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Xylo Technologies Ltd|XYLO - Company Total Debt Obligations|Debt to Book Capitalization Ratio Xylo Technologies|XYLO - Company Long-Term Indebtedness|Company Current Liabilities Xylo Technologies|Quick Ratio medigus.com

- earnings and valuation multiples information:

XYLO - Company Net Income

Initial company analysis:XYLO, Xylo Technologies Ltd.

This ratio determines the degree of financial leverage by comparing total liabilities to equity to assess the stability of the capital structure. By analyzing the change in the total debt-to-equity ratio, an investor determines the balance between bankruptcy risks and expansion rates, which is critical for Xylo Technologies Ltd. (XYLO) in maintaining its Israeli laboratories and US server capacities.

Competing companies